Abstract
Summary
Falls in older people result in substantial health burden. Compelling evidence indicates that falls can be prevented. We developed comprehensive guidelines for economic evaluations of fall prevention interventions to facilitate publication of high-quality economic evaluations of the effective strategies and aid decision making.
Introduction
The importance of economics applied to falls and fall prevention in older people has largely been overlooked. The use of different methodologies to assess the costs and health benefits of the interventions and their comparators and the inconsistent reporting in the studies limits the usefulness of these economic evaluations for decision making. We developed guidelines to encourage and facilitate completion of high-quality economic evaluations of effective fall prevention strategies.
Methods
We used a generic checklist for economic evaluations as a platform to develop comprehensive guidelines for conducting and reporting economic evaluations of fall prevention strategies. We considered the many challenges involved, particularly in identifying, measuring, and valuing the relevant cost items.
Results
We recommend researchers include cost outcomes and report incremental cost-effectiveness ratios in terms of falls prevented and quality adjusted life years in all clinical trials of fall prevention interventions. Studies should include the following cost categories: (1) implementing the intervention, (2) delivering the comparator group intervention, (3) total health care costs, (4) costs of fall-related health care resource use, and (5) personal and informal carer opportunity costs.
Conclusions
This paper provides a timely benchmark to promote comparability and consistency for conducting and reporting economic evaluations of fall prevention strategies.
Similar content being viewed by others
References
Campbell AJ, Borrie MJ, Spears GF (1989) Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 44:M112–M117
Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707
Campbell AJ, Borrie MJ, Spears GF, Jackson SL, Brown JS, Fitzgerald JL (1990) Circumstances and consequences of falls experienced by a community population 70 years and over during a prospective study. Age Ageing 19:136–141
Corso P, Finkelstein E, Miller T, Fiebelkorn I, Zaloshnja E (2006) Incidence and lifetime costs of injuries in the United States. Inj Prev 12:212–218
Wong RY, Miller WC (2008) Adverse outcomes following hospitalization in acutely ill older patients. BMC Geriatr 8:10
Iglesias CP, Manca A, Torgerson DJ (2009) The health-related quality of life and cost implications of falls in elderly women. Osteoporos Int 20:869–878
Stel VS, Pluijm SM, Deeg DJ, Smit JH, Bouter LM, Lips P (2004) Functional limitations and poor physical performance as independent risk factors for self-reported fractures in older persons. Osteoporos Int 15:742–750
Scuffham P, Chaplin S, Legood R (2003) Incidence and costs of unintentional falls in older people in the United Kingdom. J Epidemiol Community Health 57:740–744
Hornbrook MC, Stevens VJ, Wingfield DJ, Hollis JF, Greenlick MR, Ory MG (1994) Preventing falls among community-dwelling older persons: results from a randomized trial. Gerontologist 34:16–23
Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH (2009) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. Issue 2. Art. No.: CD007146.
Davis JC, Robertson MC, Ashe MC, Liu-Ambrose T, Khan KM, Marra CA (2010) Does a home-based strength and balance programme in people aged ≥80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions. Br J Sports Med 44:80–89
Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T (2010) Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int. doi: 10.1007/s00198-010-1356-5
Drummond MF, Sculpher MJ, Torrance GW, O’Brien B, Stoddart GL (2005) Methods for the economic evaluation for health care programmes, 3rd edn. Oxford University Press, New York
Beard J, Rowell D, Scott D, van Beurden E, Barnett L, Hughes K, Newman B (2006) Economic analysis of a community-based falls prevention program. Public Health 120:742–751
Stevens JA, Corso PS, Finkelstein EA, Miller TR (2006) The costs of fatal and non-fatal falls among older adults. Inj Prev 12:290–295
Seematter-Bagnoud L, Wietlisbach V, Yersin B, Bula CJ (2006) Healthcare utilization of elderly persons hospitalized after a noninjurious fall in a Swiss academic medical center. J Am Geriatr Soc 54:891–897
Lamb SE, Jorstad-Stein EC, Hauer K, Becker C (2005) Development of a common outcome data set for fall injury prevention trials: the prevention of falls network Europe consensus. J Am Geriatr Soc 53:1618–1622
Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118:622–629
Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 2:1–74, i–iv
Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60:1571–1582
Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35:1095–1108
Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5:1–30
Torrance GW (1987) Utility approach to measuring health-related quality of life. J Chronic Dis Ther Res 40:593–603
Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292
Horsman J, Furlong W, Feeny D, Torrance G (2003) The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 1:54
Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M (2002) Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 40:113–128
Harwood RH (2008) Economic evaluations of complex services for older people. Age Ageing 37:491–493
Bryan S, Hardyman W, Bentham P, Buckley A, Laight A (2005) Proxy completion of EQ-5D in patients with dementia. Qual Life Res 14:107–118
Sansoni J, Marosszeky N, Jeon Y-H, Chenoweth L, Hawthorne G, King M, Budge M, Zapart S, Sansoni E, Senior K, Kenny P, Low L (2007) Final report: dementia outcomes measurement suite project. Centre for Health Service Development, University of Wollongong, Wollongong
Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, Peters TJ (2008) Valuing the ICECAP capability index for older people. Soc Sci Med 67:874–882
Coast J, Peters TJ, Natarajan L, Sproston K, Flynn T (2008) An assessment of the construct validity of the descriptive system for the ICECAP capability measure for older people. Qual Life Res 17:967–976
Davis JC (2010) Health economic studies: a focus on health related quality of life, health resource utilization and falls prevention in vulnerable community dwelling seniors in medicine. University of British Columbia, Vancouver
Glick HA, Doshi JA, Sonnad SA, Polsky D (2007) Economic evaluation in clinical trials. Oxford University Press, New York
Oostenbrink JB, Al MJ (2005) The analysis of incomplete cost data due to dropout. Health Econ 14:763–776
Manca A, Palmer S (2005) Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl Health Econ Health Policy 4:65–75
Briggs A, Clark T, Wolstenholme J, Clarke P (2003) Missing... presumed at random: cost-analysis of incomplete data. Health Econ 12:377–392
Gardiner JC, Sirbu CM, Rahbar MH (2004) Update on statistical power and sample size assessments for cost-effectiveness studies. Expert Rev Pharmacoecon Outcomes Res 4:89–98
Briggs AH, Gray AM (1998) Power and sample size calculations for stochastic cost-effectiveness analysis. Med Decis Making 18:S81–S92
O’Hagan A, Stevens JW (2002) Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res 11:469–490
Sonnenberg FA, Beck JR (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13:322–338
Bryant T (2002) Role of knowledge in public health and health promotion policy change. Health Promot Int 17:89–98
Wiseman V, Mooney G (1998) Burden of illness estimates for priority setting: a debate revisited. Health Policy 43:243–251
Mooney G, Irwig L, Leeder S (1997) Priority setting in health care: unburdening from the burden of disease. Aust N Z J Public Health 21:680–681
Lamb SE, Hauer K, Becker C (2009) Manual for the fall prevention classification system. www.profane.eu.org/profane_documents/Falls_Taxonomy.pdf. Accessed Jan 2009
Earnshaw J, Lewis G (2008) NICE guide to the methods of technology appraisal: pharmaceutical industry perspective. Pharmacoeconomics 26:725–727
Acknowledgments
Jennifer C. Davis is funded by the Canadian Institute for Health Research Postdoctoral fellowship, Vancouver Coastal Health and the Brain Research Centre through Dr. Teresa Liu-Ambrose. Prof. Scuffham is the recipient of a National Health and Medical Research Council Career Development Award (#401742).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Davis, J.C., Robertson, M.C., Comans, T. et al. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int 22, 2449–2459 (2011). https://doi.org/10.1007/s00198-010-1482-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-010-1482-0